Clinical Trials Logo

Shock, Septic clinical trials

View clinical trials related to Shock, Septic.

Filter by:

NCT ID: NCT02508350 Recruiting - Septic Shock Clinical Trials

The Pharmacokinetics/Pharmacodynamics of High-dose Daptomycin in Patients With Septic Shock

Start date: January 2015
Phase: N/A
Study type: Interventional

The first objective of this study was to characterize the pharmacokinetics and pharmacodynamics of daptomycin with a daily dose of 12mg/kg in septic shock patient; the second objective is to identify the optimal dosing scheme for daptomycin among patients with septic shock and to enhance therapeutic outcomes.

NCT ID: NCT02473718 Completed - Septic Shock Clinical Trials

Fluid Balance in the ICU - Interventions to Minimize Fluids in Patients With Septic Shock

Start date: January 2014
Phase: N/A
Study type: Interventional

The purpose of the study is to determine if a protocol that assesses patients' daily fluid intake and output can decrease the overall amount of fluid patients receive during the first five days in the ICU. The study will also determine if decreasing overall fluids can decrease adverse events associated with mechanical ventilation, such as ventilator-associated pneumonias. The protocol will include daily ultrasounds and blood draws to evaluate fluid balance. Ultrasound will be used to measure changes in the diameter of the inferior vena cava with respiration.

NCT ID: NCT02473263 Completed - Clinical trials for Severe Septic Syndrome (Severe Sepsis and Septic Shock) Diagnosed and Treated by Mobile Intensive Care Unit

Samu Save Sepsis: Early Goal Directed Therapy in Pre Hospital Care of Patients With Severe Sepsis and/or Septic Shock

SSS
Start date: May 9, 2016
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether an aggressive strategy of severe sepsis patients since pre hospital care, including early antibiotics administration, hemodynamic optimization, and opotherapy when indicated, could reduce mortality

NCT ID: NCT02468063 Completed - Clinical trials for Cirrhosis With Septic Shock

To Assess the Efficacy of Early Introduction of a Combination of Low Dose Vasopressin Analogue in Addition to Noradrenaline as a Vasopressor in Patients of Cirrhosis With Septic Shock

Start date: May 1, 2015
Phase: N/A
Study type: Interventional

The consecutive patients admitted to Intensive care unit of Hepatology department of ILBS and full filling all the eligibility criteria will be enrolled in 1:1 ration by the process of randomization.- The study is an open level study. The investigators will strictly follow the randomization table to give therapy as per the intervention arm. - Intervention:-the therapeutic intervention is vasopressor i.e. noradrenaline alone and terlipressin along with noradrenaline to maintain the MAP >65mm Hg. - Intervention arm - Arm (A) - Noradrenaline - Arm (B) - Noradrenaline + low dose terlipressin

NCT ID: NCT02464371 Completed - Septic Shock Clinical Trials

Interest of Plasma microRNAs

µARN
Start date: May 2015
Phase: N/A
Study type: Observational

ICU acquired muscle weakness (IAMW) is a common disease that is associated with high morbidity and mortality. Patients with septic shock are particularly at risk. The diagnosis of IAMW is clinical and based on the rating of the Medical Research Council score (MRC score). A MRC score lower than 48 defines the IAMW. But this evaluation is only usable in sufficiently awaken patients. Several studies have highlighted the role of microRNAs in regulating physiological processes and diseases related to the skeletal muscles. To date, no study was interested in IAMW. The aim of this study is to compare the microRNA detection kinetics on the appearance of IAMW. In septic shock patients, the kinetics of nine microRNAs will be compared between two groups: those with IAMW (IAMW + group) and those without IAMW (IAMW - group).

NCT ID: NCT02454348 Withdrawn - Shock, Septic Clinical Trials

NOrepinephrine and VasoprEssin Versus Norepinephrine aLone in Critically Ill Patients With Septic Shock

NOVEL
Start date: November 1, 2015
Phase: Phase 4
Study type: Interventional

Sepsis, a systemic host response to the invasion of a pathogenic microorganism, may progress to severe sepsis, wherein the patient experiences acute dysfunction in at least one organ system, and further develop into septic shock if the patient cannot regain adequate systemic blood pressure and perfusion after adequate and appropriate fluid resuscitation. Further prospective study of the potential mortality benefit with combination norepinephrine and vasopressin in critically ill patients with septic shock needs to be performed. Our research will resolve this essential question and improve the scientific knowledge surrounding vasoactive medications in patients with septic shock.

NCT ID: NCT02453425 Completed - Acute Kidney Injury Clinical Trials

The Effects of Blood Pressure on Renal Function and Oxygenation in Septic Shock

Start date: May 2011
Phase: N/A
Study type: Interventional

The purpose of this study is to evaluate renal effects of 3 different levels of mean arterial pressure in early case of septic shock. In 8 patients diagnosed with early septic shock, we will adjust mean arterial pressure (MAP) to three different levels, using norepinephrine. At each level of MAP, central and renal hemodynamics and oxygenation states will be measured. Analysis will be made to describe the pathophysiology at MAP 75 mmHg, and then to evaluate at which MAP renal function and oxygenation is least affected negatively.

NCT ID: NCT02449928 Not yet recruiting - Lactate Clinical Trials

Using Sodium Lactate Ringer's Injection Resuscitate Septic Shock Patients

Start date: September 2015
Phase: N/A
Study type: Interventional

Using sodium lactate Ringer's injection resuscitate septic shock patients and Compared with other solution, in order to make clear whether can improve the prognosis.

NCT ID: NCT02442440 Completed - Septic Shock Clinical Trials

Anisodamine Critically Ill SeptIc Shock

ACIdoSIS
Start date: April 2015
Phase: Phase 1/Phase 2
Study type: Interventional

Anisodamine has been widely used in China for its pharmacological effect on improving microcirculation during shock. It has been reported that anisodamine is effective in reducing mortality rate in children with meningitis. however, its effectiveness in patients with septic shock has not been systematically investigated. The aim of the study is to investigate the effectiveness of anisodamine in the treatment of patients with septic shock.

NCT ID: NCT02430142 Completed - Sepsis Clinical Trials

Microcirculatory Oxygen Uptake in Sepsis

Start date: April 2015
Phase:
Study type: Observational

Forearm vasoocclusive testing (VOT) will be performed with laser-doppler spectrophotometry system in septic patients on ICU. Microcirculatory oxygen uptake will be checked for prognostic value and for associations with tissue hypoxia markers and high central venus saturations.